251300-29-5

Basic information

• Product Name: 5-Bromo-3-fluorosalicylic acid, 4-Bromo-2-carboxy-6-fluorophenol
• Synonyms: 5-Bromo-3-fluoro-2-hydroxybenzoic acid 97%;5-Bromo-3-fluorosalicylic acid, 4-Bromo-2-carboxy-6-fluorophenol;5-Bromo-3-fluoro-2-hydroxybenzoicacid97%
• CAS NO: 251300-29-5
• Molecular Formula: C₇H₄BrFO₃
• Molecular Weight: 235.0072632
• Mol File: 251300-29-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Bromo-3-fluorosalicylic acid, 4-Bromo-2-carboxy-6-fluorophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-3-fluorosalicylic acid, 4-Bromo-2-carboxy-6-fluorophenol(251300-29-5)
• EPA Substance Registry System: 5-Bromo-3-fluorosalicylic acid, 4-Bromo-2-carboxy-6-fluorophenol(251300-29-5)

Safety Data

• Hazardous Substances Data: 251300-29-5(Hazardous Substances Data)

Upstream product

• 341-27-5 3-fluorosalicylic acid 
• 2105-94-4 4-bromo-2-fluorophenol 
• 251300-28-4 5-bromo-3-fluoro-2-hydroxybenzaldehyde 

Downstream Products

• 341-27-5 3-fluorosalicylic acid 
• 773134-37-5 5-bromo-3-fluoro-2-hydroxybenzoic acid methyl ester 

Relevant articles and documents

TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF

The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.

Pyrrolo-pyridine kinase modulators

The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.